238 related articles for article (PubMed ID: 18460598)
21. Acylation type determines ghrelin's effects on energy homeostasis in rodents.
Heppner KM; Chaudhary N; Müller TD; Kirchner H; Habegger KM; Ottaway N; Smiley DL; Dimarchi R; Hofmann SM; Woods SC; Sivertsen B; Holst B; Pfluger PT; Perez-Tilve D; Tschöp MH
Endocrinology; 2012 Oct; 153(10):4687-95. PubMed ID: 22865372
[TBL] [Abstract][Full Text] [Related]
22. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.
Ali S; Chen JA; Garcia JM
Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681
[TBL] [Abstract][Full Text] [Related]
23. Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity.
Hassouna R; Labarthe A; Zizzari P; Videau C; Culler M; Epelbaum J; Tolle V
Front Endocrinol (Lausanne); 2013; 4():25. PubMed ID: 23515849
[TBL] [Abstract][Full Text] [Related]
24. Ghrelin in the control of energy, lipid, and glucose metabolism.
Heppner KM; Müller TD; Tong J; Tschöp MH
Methods Enzymol; 2012; 514():249-60. PubMed ID: 22975057
[TBL] [Abstract][Full Text] [Related]
25. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
[TBL] [Abstract][Full Text] [Related]
26. Focus on the short- and long-term effects of ghrelin on energy homeostasis.
De Vriese C; Perret J; Delporte C
Nutrition; 2010 Jun; 26(6):579-84. PubMed ID: 20080032
[TBL] [Abstract][Full Text] [Related]
27. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
Bresciani E; Rizzi L; Molteni L; Ravelli M; Liantonio A; Ben Haj Salah K; Fehrentz JA; Martinez J; Omeljaniuk RJ; Biagini G; Locatelli V; Torsello A
Endocrine; 2017 Oct; 58(1):106-114. PubMed ID: 27896546
[TBL] [Abstract][Full Text] [Related]
28. Thermogenic characterization of ghrelin receptor null mice.
Lin L; Sun Y
Methods Enzymol; 2012; 514():355-70. PubMed ID: 22975064
[TBL] [Abstract][Full Text] [Related]
29. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
Salomé N; Haage D; Perrissoud D; Moulin A; Demange L; Egecioglu E; Fehrentz JA; Martinez J; Dickson SL
Eur J Pharmacol; 2009 Jun; 612(1-3):167-73. PubMed ID: 19356720
[TBL] [Abstract][Full Text] [Related]
30. Circulating ghrelin and leptin concentrations and growth hormone secretagogue receptor abundance in liver, muscle, and adipose tissue of beef cattle exhibiting differences in composition of gain.
Jennings JS; Wertz-Lutz AE; Pritchard RH; Weaver AD; Keisler DH; Bruns K
J Anim Sci; 2011 Dec; 89(12):3954-72. PubMed ID: 21724941
[TBL] [Abstract][Full Text] [Related]
31. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
32. The role of ghrelin and ghrelin analogues in wasting disease.
Kamiji MM; Inui A
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
[TBL] [Abstract][Full Text] [Related]
33. Novel analogs of ghrelin: physiological and clinical implications.
Halem HA; Taylor JE; Dong JZ; Shen Y; Datta R; Abizaid A; Diano S; Horvath T; Zizzari P; Bluet-Pajot MT; Epelbaum J; Culler MD
Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S71-5. PubMed ID: 15339248
[TBL] [Abstract][Full Text] [Related]
34. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.
DeBoer MD
Curr Pharm Des; 2012; 18(31):4779-99. PubMed ID: 22632859
[TBL] [Abstract][Full Text] [Related]
35. Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis.
Su J; Geng J; Bao J; Tang Y; Liu M; Yu H; Han Y; Huang W; Zhou S
Nutr J; 2016 Nov; 15(1):97. PubMed ID: 27852245
[TBL] [Abstract][Full Text] [Related]
36. The atypical antipsychotic, olanzapine, potentiates ghrelin-induced receptor signaling: An in vitro study with cells expressing cloned human growth hormone secretagogue receptor.
Tagami K; Kashiwase Y; Yokoyama A; Nishimura H; Miyano K; Suzuki M; Shiraishi S; Matoba M; Ohe Y; Uezono Y
Neuropeptides; 2016 Aug; 58():93-101. PubMed ID: 26775231
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
38. Peripheral leptin and ghrelin receptors are regulated in a tissue-specific manner in activity-based anorexia.
Pardo M; Roca-Rivada A; Al-Massadi O; Seoane LM; Camiña JP; Casanueva FF
Peptides; 2010 Oct; 31(10):1912-9. PubMed ID: 20600421
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?
DeBoer MD
Mol Cell Endocrinol; 2011 Jun; 340(1):97-105. PubMed ID: 21354462
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function.
Ledderose C; Kreth S; Beiras-Fernandez A
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):1-6. PubMed ID: 22074572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
